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Abstract
In the past decade, there has been rapid scale-up of insecticide-based malaria vector con‐
trol in the context of integrated vector management (IVM). But, the continued efficacy of
vector control interventions is threatened by the selection of insecticide resistance. Evi‐
dence of insecticide resistance operationally undermining malaria vector control pro‐
grammes is invariably mounting and is resulting in policy changes. Monitoring and
management of resistant disease vectors is essential to limit the selection and spread of
insecticide resistance and to maintain the effectiveness of vector control. Thus, countries
are encouraged to implement pre-emptive insecticide resistance management (IRM) strat‐
egies against malaria vectors according to the Global Plan for IRM. However, substantial
challenges for implementation exist at country level. The IVM strategy provides a poten‐
tial platform that could be exploited for enhanced national strategic IRM planning and
operationalisation. Nevertheless, significant coordinated response among stakeholders
and political commitment is needed for timely and effective policy implementation with‐
in the context of a national health system.
Keywords: Malaria vector control, integrated vector, management strategic planning, in‐
secticide resistance management
1. Introduction
Malaria remains a vector-borne disease of major public health significance globally [1]. It is
estimated that about 198 million annual cases of malaria and a related 584,000 deaths occur
worldwide [2]. Insecticide-based vector control in the context of integrated vector management
(IVM) has a long-standing, proven record of preventing, reducing, and eliminating vector-
borne diseases [3]. However, its continued efficacy is threatened by the selection of insecticide
resistance in disease vectors coupled with the lack of sustainable financial resources [4],
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scarcity of requisite skills, and minimal or lack of collaboration between health and other
relevant sectors to effectively monitor and manage it [3]. Evidence of insecticide resistance
operationally undermining malaria vector control is mounting and is resulting in policy
changes [5]. Monitoring and management of resistant disease vectors is essential to limit the
selection and spread of insecticide resistance and to maintain the effectiveness of vector control
[6]. Nevertheless, substantial challenges for implementation exist at country level. Thus,
countries are encouraged to implement pre-emptive insecticide resistance management (IRM)
strategies against malaria vectors according to the Global Plan for IRM (GPIRM) [7]. While
IVM and IRM are the recommended approaches for combating vector-borne diseases and
preventing the spread of resistance respectively, operational experience for both strategies is
limited to relatively few countries. However, IVM provides a potential platform that could be
exploited for enhanced national strategic IRM planning and deployment. This chapter reviews
the distribution, mechanisms, and resistance management strategies in malaria vectors
including the challenges experienced in operational settings. A framework of policies and
strategies to facilitate the implementation of the GPIRM using the IVM platform is also
presented and accentuates coordinated response among stakeholders and political commit‐
ment for effective policy execution within the context of national health systems.
2. Literature search strategy
Information sources for this review included all available data and accessible archived
documentary records on malaria vectors and insecticide resistance. Structured literature
searches of published, peer-reviewed sources using online scientific bibliographic databases
were utilised to gather pertinent data. This was conducted via systematic literature search of
Library catalogues and online electronic databases, particularly PubMed [8], the WHO Library
Database [9], Google Scholar [10], the African Journals Online, the Armed Forces Pest Man‐
agement Board [11], and the research for life databases (AGORA, ARDi, HINARI, and OARE)
were used to search for relevant literature. All digital electronic database searches for peer-
reviewed, published work used a combination of key search terms: 1) Anopheles malaria vectors
complex and one of the following terms; 2) insecticide resistance; 3) resistance mechanisms; 4)
resistance management; 5) impact of resistance; 6) malaria vector control; and 7) malaria
epidemiology. Reference sections of all relevant articles were also reviewed to identify more
literature. Additional non-peer reviewed literature were examined for information related to
the subject. Articles that report biochemical and molecular tools for resistance monitoring were
also retrieved. The inclusion criteria considered all manuscripts and publications in English
language that report on selection of insecticide resistance in malaria vectors, causes and
mechanisms of resistance, vector resistance and the epidemiology of malaria, integrated vector
management (IVM), resistance patterns, and the impact in malaria vectors.
3. Classification and distribution of malaria vectors
Mosquitoes  belong  to  the  family  Culicidae  in  the  order  Diptera,  class  Insecta,  phylum
Arthropoda [12]. Culicidae is divided into three subfamilies Anophelinae, Culicinae, and
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Toxorhynchitinae, and comprises approximately 3,450 recognised species of mosquitoes in
38 genera. The 34 genera are in the subfamily Culicinae, 3 in Anophelinae, and only 1 in
Toxorhynchitinae [13]. Malaria vectors belong to the genera Anopheles  (Cellia) Myzomyia
and their global distribution has been recognised in six zoo-geographical regions: Palaearc‐
tic,  Oriental,  Australasian,  Afro-tropical,  Neoarctic,  and  Neotropical  regions  [14,  15].
Globally,  about  465  species  have  been  described  in  the  genus  Anopheles  with  seven
subgenera  that  vary  in  species  composition,  i.e.,  Anopheles  (182  species),  Baimaia  (one
species), Cellia  (220 species), Kerteszia  (12 species), Lophopodomyia  (six species), Nyssorhyn‐
chus (39 species), and Stethomyia (five species) [16]. However, the species able to transmit
parasites that cause human malaria only belong to the subgenera, Anopheles, Cellia, Kerteszia,
and Nyssorhynchus [17]. Only about 80 species are capable of transmitting malaria, 70 species
are vectors of malaria under natural conditions and about 45 are of major significance [13].
The distribution of major vectors of malaria is determined mainly by temperature and the
capacity of the air to desiccate the insect [18].
The global distribution of principal vectors of malaria is associated with 12 epidemiological
zones of malaria: North America (An. freeborni and the An. quadrimaculatus), Central America
(An. albimanus, An. Aquasalis, An. pseudopunctipennis, An. argyritarsis, and An. darlingi,), South
America (An. darlingi, An. albitarsis, An. Aquasalis, An. marajoara, An. nuneztovari, and An.
pseudopunctipennis), Afro-tropical (Anopheles gambiae Giles 1902 and Anopheles arabiensis Patton
in the An. gambiae complex, and Anopheles funestus s.s. Giles 1900 in the An. funestus complex
[19, 20] with An. merus, An. melas, An. moucheti, An. pharoensis, and An. nili implicated in
transmission in localised areas [21, 22]), North Eurasian (An. atroparvus), Mediterranean (An.
atroparvus, An. labranchiae, An. messeae, An. sacharovi, An. sergentii, and An. superpictus), Afro-
Arabian (An. arabiensis, An. pharoensis, and An. sergenti), Indo-Iranian (An. culicifacies and An.
fluviatilis), Indo-Chinese Hills (An. dirus, An. fluviatilis, and An. minimus), Malaysian (An.
campestris, An. donaldi, An. letifer, An. nigerrimus, An. aconitis, An. balabacencis, An. dirus, An.
flavirostris, An. leucosphyrus, An. ludlowea, An. maculates, An. minimus, An. subpictus, and An.
sundaicus), Chinese (An. barbirostris, An. lesteri, An. sinensis, An. aconitus, An. annularis, An.
balabacensis, An. culicifacies, An. dirus, An. farauti, An. flavirostris, An. fluviatilis, An. koliensis, An.
leucosphyrus, An. maculates, An. minimus, An. punctulatus, An. stephensi, An. subpictus, and An.
sundaicus), and Australasian (An. farauti, An. punctulatus s.s., and An. koliensis) [15, 23]. Notably,
malaria vector bionomics and their ecological variations have implications for their control.
4. Insecticides and malaria vector control
The classes of insecticides most commonly used for contemporary malaria vector control
include organochlorines, organophosphorus, carbamates, and pyrethroids [24]. The first
synthetic organochlorine insecticide to be commercialised, DDT (dichlorodiphenyltrichloro‐
ethane), was central to the World Health Organisation (WHO)-led global malaria eradication
campaign (1955–1969) [25]. Except in sub-Saharan Africa, this resulted in the elimination of
the disease in North America, Europe, and parts of Asia [26]. While agricultural use of DDT
has now ceased due to environmental persistence and reduced efficacy against resistant
insects, extensive use for malaria control continues as a cost-effective and safe insecticide for
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indoor residual spraying (IRS). More recently, pyrethroids have been widely used for malaria
control. They are the only class of insecticides recommended by the WHO for impregnation
of long-lasting insecticidal bed nets (LLINs) [24] and are also available for IRS. Pyrethroids,
such as permethrin and deltamethrin, and the pseudo-pyrethroid etofenprox, including DDT
and its analogues, share a similar mode of action of targeting the sodium channels of the nerve
membranes. Carbamates, such as bendiocarb, share the same mode of action as organophos‐
phates, such as pirimiphos methyl, malathion, and temephos, binding to acetylcholinesterase
at the nerve junction [27]. Chlorfenapyr has a different mode of action involving disruption of
oxidative phosphorylation and consequently the disruption of the conversion of ADP to ATP
in mitochondria [28]. Although insecticides from different chemical classes are available as
larvicides (e.g., temephos), the arsenal of insecticides recommended for IRS is limited to four
classes only [29]. The selection of DDT resistance in malaria vectors resulted in the declining
political and financial support for the Global Malaria Eradication Campaign launched by the
WHO [30].
Vector control, personal protection, and community participation are the pillars of WHO
strategies for insect-transmitted disease control. IVM has been advocated for as a recommend‐
ed approach for combating vector-borne diseases in the past decade [31]. IVM is defined as “a
rational decision-making process for optimal use of resources for vector control”. The objective
of vector control is to reduce and/or interrupt transmission of malaria by preventing human
contact with malaria-bearing mosquitoes, eliminating breeding sites, killing the mosquito
larvae, or reducing the longevity of adult mosquitoes [30]. The use of IRS and LLINs are the
mainstream contemporary malaria vector control interventions [32, 33]. The efficacy of these
two methods has been evaluated in different epidemiological settings [34] at experimental field
trial [35, 36] and community-wide levels [37, 38]. In reducing abundance and infectivity of
malaria vectors, these tools reduce overall transmission and protect all individuals within a
community [35], albeit with variation in responsiveness amongst vector populations. Present‐
ly, there is mounting evidence that combining IRS and insecticide treated nets (ITNs) affords
enhanced protection to exposed populations compared to using one method alone [39]. As
such, deployment of these interventions together in high malaria risk areas has been advocated
[35, 40, 41]. Although these two interventions have been critical in providing community
protection, the optimal policy for their co-implementation still remains to be determined.
Moreover, the growing resistance of malaria vectors to available insecticides is a major cause
for concern and an increasing threat to such essential and effective interventions [24, 42, 43].
In light of the inherent heterogeneity in the responsiveness of malaria vectors to control, the
core interventions can be supplemented in specific locations by larval source management
(LSM) strategies (e.g., larviciding, biological control, and environmental management) in the
context of IVM [44, 45]. Larvivorous fishes or bacterial pathogens such as Bacillus thuringien‐
sis israelensis and Bacillus sphaericus are examples of biological agents that are used to kill
larvae [46]. Temephos is the commonly used chemical larvicide. The environmental meth‐
ods to prevent malaria include elimination of breeding sites by drainage or by applying
locally  grown  plants.  With  the  selection  of  resistance,  new  insecticides,  and  novel  ap‐
proaches to vector control must be developed. Effective and sustained malaria vector control
requires  clear  commitment  from national  authorities,  including  long-term support  from
funding  partners  [47].  Several  malaria  control  programmes  have  fragmentary  empirical
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evidence to inform policy formulation for rational vector control. For this reason, malaria
control programmes are encouraged to adopt the WHO-led IVM strategy [48], which should
be  an  evidence-based  decision  making  process  that  requires  coherent  monitoring  and
evaluation component [49]. This should include routine surveillance of resistance profiles of
major malaria vectors and potential resistance mechanisms to facilitate informed decisions
and policy changes, such as the incorporation of insecticide resistance management opera‐
tions into control programmes [29].
5. Insecticide resistance in malaria vectors
The selection of insecticide resistance in malaria vectors has the potential to compromise
effective control of vector-borne diseases. Resistance is defined as “the development of an
ability in a strain of some organism to tolerate doses of a toxicant that would prove lethal to a
majority of individuals in a normal population of the same species” [27, 29]. Alternatively, a
resistant phenotype has been defined as an insect that survives a dose of insecticide that would
normally have killed it [50, 51]. This heritable change in the sensitivity of a vector population
is reflected in the repeated failure of a product to achieve the expected level of control when
used according to the label recommendation for that disease vector species [52]. The biological
phenomenon is a genetically inherited characteristic that develops as a result of selective effects
of the relevant insecticidal compound or its analogue and increases in the vector population
[15]. In mosquitoes, genetic and phenotypic resistance results from a mutation or gene
duplication leading to the alteration of a normal physiology, morphology, or behaviour of the
individual phenotype. In this regard, the sensitivity of the nervous system to the insecticide is
reduced or the process of detoxification of the insecticide is enhanced. When an insecticide is
applied, susceptible individuals are less likely to survive relative to the resistant individuals.
The consequence is the propagation and exponential increase in the frequency of the resistance
gene within the population over time [29].
Resistance is a multidimensional biological phenomenon that depends for its development on
the interaction of multiple influences [27]. The evolution of insecticide resistance is complex
and depends on several genetic, biological, and operational factors [53, 54]. The genetic factors
include the intrinsic characteristics of the resistant genes (e.g., mono versus polygenic resist‐
ance, dominance, fitness cost, and gene interaction), while the biological factors relate to the
life cycle of the insect (e.g., rate of reproduction, number of generation/offspring, and rate of
migration and isolation). Behavioural/ecological encompass, migration in and out of exposed
population, avoidance of the insecticide, effects of age and natural inducers on degradative
enzymes, and endophagy/exophagy. Operational factors concern the treatment itself, includ‐
ing the method and frequency of application, dosage, and residual activity of the insecticides
as well as insecticide coverage [55]. Among known and potential factors affecting the evolution
of resistance, the operational factors are the only ones open to manipulation by man. Therefore,
investigation on the development of resistance should ideally take into account of all these
factors.
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The level of resistance in insect populations is dependent on the amount and frequency of
insecticides used, and the inherent characteristics of the insect species selected. Mosquitoes,
for instance, are endowed with all attributes suited for rapid resistance development including
high reproductive potentials and short life cycles producing several generations per season
with abundant progeny [27, 52]. Mostly resistance in a particular species is considered to occur
throughout the control area, but in reality, insecticide resistance can be focal in nature and is
very heterogeneous even over very small distances. It often develops within a small part of
the population of one species of Anopheles and assumes different patterns depending on the
type of selection pressure [27]. In Guatemala, sampling sites for Anopheles albimanus only a few
kilometres apart varied not only by presence or absence of resistance, but also by level of
resistance and the mix of mechanisms responsible for resistance [56]. The WHO Global
Technical Strategy for Malaria 2016–2030 highlights insecticide resistance as a major obstacle
to achieving malaria control targets [57]. The current major emphasis in research into vector
resistance is double pronged. The first approach strives towards understanding the molecular
mechanisms underlying resistance with the view of developing novel vector-control methods
that avoid or minimise resistance problems. The second approach to research involves rational
resistance management, which is developing and implementing control methods that mini‐
mise the likelihood that vectors will evolve strong resistance to important insecticides [58].
6. Methods for detecting insecticide resistance
Information on insecticide resistance is important to inform effective vector control policy
formulation. As such, detection and monitoring of insecticide resistance in malaria vectors is
crucial and has to be conducted together with other entomological surveys [29]. Insecticide
resistance can be detected and investigated at many levels; from dose-related phenotypical
observations and genotypic approaches ranging from molecular characterisation of genes
conferring resistance and their biochemical products, to the role these gene products play in
overcoming the toxic effects of insecticides. In order to detect resistance, one needs to be
continually looking for it. Measuring phenotypic resistance using bioassays is the recom‐
mended initial step in establishing resistance levels before genotyping for target-site and
metabolic resistance and biochemical assays [59, 60]. Establishing an effective resistance
management plan requires simple assays to monitor and evaluate insecticide resistance and
its underlying mechanisms. To this end, different biochemical and molecular approaches have
been devised, some of which are amenable for field operations. The contemporary applicable
methods for resistance monitoring of field populations of mosquitoes are outlined below:
WHO Diagnostic Assays: A bioassay is used to determine the relationship between a physio‐
logically active agent and the effect that it produces in a living organism [61, 62]. Bioassays
with the dosage or the exposure time as the variable are carried out to test the resistance status
of insect populations. The WHO diagnostic assay is a useful and handy approach to detect
resistance. Insecticide impregnated filter paper is used as a contact surface for exposed
mosquitoes. The assay uses insecticide discriminating dosages twice the LD99 that kills 100%
of non-blood-fed, adult-susceptible Anopheline mosquitoes of known age [59, 63, 64]. The
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demerits associated with the assays include: the assay is only able to detect high levels of
resistance, i.e., if more than 5% of insects survive the exposure, with the potential exception of
dieldrin bioassays, they cannot monitor resistance gene frequencies accurately; cannot give an
indication of the underlying mechanisms of resistance; and cannot be used to predict cross-
resistance between insecticides [29]. Therefore, the resistance status detected using bioassays,
can then be further studied by looking at the mechanisms responsible for resistance using
biochemical and molecular assays.
CDC Bottle Assay: These are similar to the WHO discriminating dose assays. However, the CDC
bottle assay relies on time mortality data, which are measures of the time it takes an insecticide
to penetrate a vector, traverse its intervening tissues, get to the target site, and act on that site.
Mosquitoes are exposed to glass bottle surfaces coated with an acetone- or alcohol-based
formulation of insecticides. The advantage of this assay is that the rate of insecticide knock
down can easily be scored during the course of the exposure period. It is able to give predictive
kdr-type resistance mechanism with rapid acting insecticides, such as pyrethroids. However,
caution should be exercised, as metabolic resistance mechanisms are capable of eliciting
reduced knock-down phenotype without any concomitant change in sensitivity at the sodium
channel target site [65].
Synergists: Synergists are enzyme inhibitors of insecticide detoxification enzymes. The
synergists, piperonyl butoxide (PBO) and S, S, S- tributylphosphorotrithioate (DEF) are
inhibitors of monooxygenases and esterases respectively [64, 66]. Glutathione s-transferase
activity is inhibited by Ethacrynic acid (EA), diethyl maleate (DM), and chlorfenethol (CF). By
inhibiting specific detoxification enzymes, insecticide synergists can reduce or eliminate the
selective advantage of individuals possessing over-expressed or mutated enzymes [67].
Therefore, they are used to suggest the type of metabolic resistance mechanisms present in
insect populations [68]. For example, they are used in bioassays to counteract or inhibit the
enzymes responsible for resistance to the insecticide. Some are used in control to reduce the
dose or rate of application [64]. For example, piperonyl butoxide is commonly added to
pyrethroid-based aerosol formulations to decrease the time to knock down and increase the
time to recover from the insecticide.
Biochemical Assays: There are two ways that metabolic enzymes can produce resistance [69];
overproduction of the enzyme, which leads to either increased metabolism or sequestration
of the insecticide and an alteration in the catalytic centre activity of the enzyme, which increases
the rate of insecticide metabolism by the enzyme. Sequestration occurs when the overproduced
enzyme rapidly binds and slowly metabolises the insecticide, therefore preventing it from
reaching the target site within the insecticide [70]. With sequestration, the resistance level is
proportional to the increase in the quantity of the enzyme produced because of the slow
insecticide turn-over rate [70]. Biochemical assays are used to give a first indication of the
enzyme system involved in resistance [69]. A number of simple biochemical assays [71] are
available to detect increased activity of three enzyme systems, esterases [72, 73], glutathione-
S-transferases (GST) [74, 75], and cytochrome P450-dependent monoxygenases (P450s) [76]
involved in insecticide metabolism. Many of these assays detect increased enzymatic activity
against model substrates in resistant individuals. While simple microtitre plate assays to
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measure AChE insensitivity using a carbamate or an oxon analogue of a phosphorothioate
insecticide exist [77], the applicability of biochemical assays for the GSTs and P450s are not
easily amenable in the field [29].
Molecular Assays: Molecular techniques can be used to detect some well-characterised resist‐
ance mechanisms. Most techniques employ the method of polymerase chain reaction (PCR).
Mutations in the insecticides' target site lend themselves to detection through simple PCR
assays, which can readily be used in many field settings. Allele-specific PCR assays have been
developed for three major target sites, the GABA receptors [78, 79], the sodium channels (kdr)
[80, 81], and AChE. The challenge is to adapt these assays for high-throughput field applica‐
tions as they have the advantage of detecting heterozygous-resistant individuals that may be
missed by other assays [29]. Recent advances in genomics have allowed a much more rapid
identification of genes that are up or down regulated in insecticide resistant insects using
microarray technology [82]. The detoxification microarray chip, developed for An. gambiae,
contains all potential insecticide resistance genes. The detoxification chips have been devel‐
oped for An. stephensi, pyrethroid resistant An. funestus, and A. aegypti [29].
Bioassay data as measured by either the CDC or WHO technique have a common limitation
of inability to accurately determine gene frequency or predict the epidemiological impact of
resistance [83]. Resistance management requires that resistance is detected at very low
frequencies, but the two approaches are not sensitive enough to achieve this. While contem‐
porary techniques diverge in their sophistication and ease of use, there is still a need for
approaches to enable measurement of the frequency of different mechanisms of resistance in
mosquito populations [29].
7. Insecticide resistance mechanisms
In mosquitoes, resistance is mediated through complex mechanisms, including behavioural
and/or physiological changes resulting in insecticide avoidance (reduced contact with
insecticide), reduced cuticular penetration (of the insecticide through the cuticle), increased
sequestration (i.e., stored in the body where it is not harmful), target site insensitivity (i.e., the
target site is altered and not affected by the insecticide), or increased bio-degradation (so that
it is detoxified before it reaches the target site) [84], and possible increased excretion. The
molecular basis of insecticide resistance has been attributed to the existence of mutations in
target site genes or metabolic alterations at the level of the activity of the detoxification proteins
[56, 85]. Insecticide resistance mechanisms have a biochemical basis and target-site resistance
and detoxification enzyme-based resistance remain the two major forms of biochemical
resistance [52, 56]. Alone or in combination, target site resistance, which results from the
inability of the insecticide to bind to its target, and metabolic resistance resulting from failure
of the insecticide to reach its site of action due to enhanced levels of modified activities of
detoxification enzymes, confer various levels of resistance to all classes of insecticides [84].
Though long- and well-recognised, the importance of behavioural and cuticular resistance in
malaria vectors has been largely overlooked. While resistance arises through Darwinian
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selection in a population, it is often a combination of factors that results in the overall expres‐
sion of the phenomenon [15]. Thus, gene over-expression, amplification, and structural
mutations have been linked to insecticide resistance mechanisms in some insects [84]. Cogni‐
zant of detailed elaborations given elsewhere [86], a brief description of the key mechanisms
is outlined below:
Target site resistance (also called phenotypic resistance) is based on alterations of amino acids
in the site of action where the insecticide is supposed to bind, rendering them less sensitive to
the active ingredient [58]. Majority of insecticides used in vector control are nerve poisons and
target: the acetylcholinesterase (AChE) that hydrolyses the neurotransmitter acetylcholine in
the synapses particularly in carbamates and organophosphates; the sodium channels respon‐
sible for raising the action potential in the neurons during the nerve impulses involved in the
resistance in organochlorines and pyrethroids; or the c-aminobutyric acid (GABA) receptors
responsible for chloride-ion neurotransmission in the nervous system, specific for cyclodienes
[87, 88]. Mutations have been observed in neuronal enzymes and receptors, leading to well-
defined target site alteration and resistance to chemical insecticides [89]. Knock down resist‐
ance (Kdr) occurs due to a single or multiple substitutions/mutations in the para-gated sodium
channel gene [29]. In An. gambiae, two mutations (Leu-Phe [90] and Leu-Ser [91]) have been
identified at the same codon. As this is the target site of DDT and pyrethroids, this mechanism
produces cross-resistance to the two insecticide classes. Organophosphate and carbamate
insecticides inhibit acetylcholinesterase (AChE). Many insect vectors have developed resist‐
ance through structural alterations of this target site [58]. These point mutations may act
individually or in combination.
Metabolic resistance, on the other hand, usually involves over-expression/over-production of a
complex array of specific enzymes capable of detoxifying insecticides or modifications in the
amino acid sequences that cause alterations in the levels and activity of detoxifying proteins
[58, 90]. The mechanism of increased detoxification contributes to a decrease in the effective
dose of insecticides available at the target site [67]. The overproduction of these endogenous
detoxifying enzymes may be achieved via two nonexclusive mechanisms: 1) increase in the
gene’s copy number of available molecules (by gene amplification or expression activation);
or 2) mutation in the enzyme coding portion of the gene, so that its product metabolises the
insecticide more efficiently [92], preventing it from reaching its target in the nervous system.
Metabolic resistance occurs through increased biodegradation of the insecticide, usually
through overproduction of detoxification enzymes such as P450s, GST, and carboxylesterases
(EST). The P450 cytochromes primarily metabolises pyrethoids and to a lesser extent, of
carbamates and organophosphates, carboxylesterases largely detoxify organophosphate and
carbamate and to a lesser extent in pyrethroid resistance [93]. GSTs are involved in the
detoxification of a wide range of xenobiotics, including the organochloride insecticide DDT
[94]. In A. gambiae, metabolic resistance to insecticides can be conferred by elevation in the
activity of these three classes of detoxifying enzymes. In contrast, there are few examples in
literature regarding insect behavioural changes and tegument alterations.
Behavioural resistance involves behaviour changes in response to prolonged exposure to an
insecticide resulting in avoidance and reduced contact with lethal doses of an insecticide [95].
Optimizing Strategic Insecticide Resistance Management Planning in Malaria Vectors
http://dx.doi.org/10.5772/61301
163
Behavioural resistance does not have the same “importance” as physiological resistance but
may be considered to be a contributing factor [96, 97]. It remains unclear whether adaptation
of malaria vectors species to insecticidal-based vector control interventions may result from a
phenotypic plasticity or from selected behavioural traits [98]. Notably, behavioural resistance
is characteristically difficult to quantify [99].
Penetration resistance: Reduced penetration involves changes that decrease the rate of penetra‐
tion or absorption of insecticide through the insect cuticle or digestive tract linings and confers
low levels of resistance [68, 100]. This resistance mechanism is not specific and can affect a
broad range of insecticides. Reduced uptake of insecticide, often referred to as cuticular
resistance, is frequently described as a minor resistance mechanism. More effort is required to
identify the significance of cuticular resistance in phenotypic resistance [86].
The understanding of the development of resistance and the design of novel strategies to
manage it and to effectively control disease vectors is greatly owed to the characterisation of
genes and the molecular mechanisms involved in insecticide resistance [101]. However, the
mechanisms of insecticide resistance are generally far less well-understood. Particularly, the
contribution these enzymes make towards pyrethroid resistance and their biochemical
relationships with P450-mediated resistance is still unclear [84].
8. Distribution of insecticide resistance
The emergence and spread of insecticide resistance to all four classes of insecticides useful in
public health invariably threatens the effectiveness of malaria vector control as most pro‐
grammes rely heavily on insecticide usage [60]. Resistance has been observed in more than 500
insect species worldwide, among which over 50 Anopheles species (Diptera: Culicidae) are
responsible for the transmission of malaria parasites to humans [13, 58]. Globally, resistance
to at least one insecticide has been identified in 64 countries with on-going malaria transmis‐
sion [7]. Currently, 27 countries in sub-Saharan Africa have reported pyrethroid resistance in
Anopheles vectors [102]. The real figure could very well be higher, as a lack of in-country
resistance monitoring prevents accurate assessment [60]. Insecticide resistance is a focal
phenomenon and as such is not evenly distributed among vector species and varies markedly
from one place to the other. Several platforms are available online with vast information on
the distribution of insecticide resistance in malaria vectors such as: Anobase (http://
anobase.vector‐base.org/ir/), Arthropod Pesticide Resistance Database (http://www.pestici‐
deresistance.org), MARA (http://www.mara.org.za), and IR mapper (http://www.irmap‐
per.com). Persuasive evidence for the presence of resistance in primary vector species to all
available insecticides has been presented from Africa, Southeast Asia and India, and South
and Central America. Corbel and N’Guessan present a detailed description of the country by
country situation analysis of resistance in these regions [86]. A summary is presented below:
In Africa, target-site and metabolic-mediated resistance has been detected in An. gambiae s.l.
malaria vectors across the continent south of the Sahara. Most of the documented evidence
comes from west Africa where pyrethroid resistance is predominant in An. gambiae s.s.
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compared to An. arabiensis [102, 103]. High levels of resistance have also been extensively
reported in the two major vectors in Central, East, Austral, and South African countries [104,
105]. Two kdr alleles exist in An. gambiae s.s. and An. arabiensis, the L1014S gene originally from
East Africa [90] and the 1014F gene of west African origin alleles [91]. Both mutations have
also been reported to co-exist in Gabon and Cameroon [106] and in Uganda [107]. The western
kdr was also detected in Kenya [108], Tanzania [109], and also in Zambia [110, 111]. In
pyrethroid-resistant An. gambiae s.l. metabolic resistance involving increased levels of P450 has
been reported in several countries with CYP6P3 and CYP6M2 genes over-expressed [112,
113]. Most data on resistance in An. funestus comes from South African countries where the
species seems to be the predominant malaria vector [101]. In An. funestus, pyrethroid resistance
involving increased activity of P450 monooxygenase and/or GST was demonstrated in
Southern Africa [114–116] with over-expressed CYP6M7, CYP6P9a, and CYP6P9b genes [117].
Pyrethroid resistance in An. funestus has also been detected in East [118] and West Africa [119,
120]. Recently, the spatial scale of the problem in sub-Saharan Africa was brought to the fore
through the IRMapper [105].
Southeast Asia and India insecticide resistance has been detected in the main malaria vector
species [87]. In the Mekong region, Anopheles dirus s.s. [121] and Anopheles minimus s.l. [122].
No kdr mutation has been observed so far in these species [123] and pyrethroid resistance
seems to result from increased detoxification by esterases and/or P450 monooxygenases [124].
Esterase-mediated pyrethroid detoxification in both An. epiroticus and An. subpictus and GST-
mediated DDT resistance in An. subpictus have been reported [121]. An. vagus and An sinen‐
sis are resistant to pyrethroids with high 1014S kdr alleles [124–127]. The presence of the 1014F
allele has been revealed in An. sundaicus, An. aconitus, An. subpictus, and An. vagus [128] (http://
www.itg.be/malvecasia/). In India, An. culicifacies s.l. has developed strong resistance to
pyrethroids [129], DDT [130, 131], dieldrin/HCH [132], and malathion [131]. Both 1014F and
1014S kdr phenotypes have been detected in pyrethroid and DDT-resistant An. culicifacies s.l.
[130] and An. stephensi [134] with elevated activities of GST in DDT resistance in this mosquito
species [135]. An. annularis, An. subpictus, and An. philippinensis are resistant to pyrethroid,
DDT, and/or dieldrin/HCH [135]. In Sri Lanka, metabolic resistance involving carboxylester‐
ases (malathion) or monooxygenases and GSTs (DDT) has been detected in An. culicifacies s.l.
and An. subpictus [136, 137]. In Bangladesh, An. philippinensis, An. maculatus s.l., and An.
aconitus have all developed resistance to DDT [138]. An. stephensi and An. sacharovi in Iran and
Turkey are resistant to DDT and dieldrin [139–141]. While An. maculatus s.l. and An. Aconi‐
tus have developed resistance to DDT in Nepal, An. stephensi is resistant to malathion in
Pakistan [142].
In Central and South America, the primary malaria vectors are An. darlingi and An. albima‐
nus. In Mexico, An. albimanus exhibits high levels of DDT and pyrethroid-resistance with
elevated levels of GST, P450, and esterases, and iAChE-mediated carbamate and organophos‐
phate resistance [143, 144]. In Peru, An. Albimanus is resistant to pyrethroids [145]. In Colombia,
DDT resistance has been reported in An. darlingi [146, 147] and pyrethroid resistance in both
An. darlingi and An. albimanus [148]. In An. darlingi, both multi-function oxidase (MFO)- and
non-specific esterase (NSE)-based metabolic resistance were reported in a deltamethrin and
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DDT-resistant population [149]. An. Nuneztovari, a secondary malaria vector, is resistant to
organophosphate and pyrethroids [150].
9. Resistance and vector control
Insecticide resistance has been perceived to have the potential to undermine efforts to control
vector-borne diseases including malaria [151, 152]. However, the impact of resistance on the
ability of malaria control intervention to reduce disease transmission is poorly understood
[153]. Insecticide resistance triggers a chain reaction that through deteriorated efficacy leads
to vector control failure and disease control failure may be expected [153]. Evidence linking
the potential of ITNs increasing phenotypic resistance and kdr frequency [154, 155] that
threaten to compromise their effectiveness exists [86]. However, whether these various forms
of resistance have an impact on the effectiveness of ITNs in malaria control remains a topic of
debate among policy makers and researchers [60]. Conclusive evidence of insecticide resist‐
ance impacting on the efficacy of vector control interventions in decreasing disease transmis‐
sion is by large still absent. However, minimal evidence of an effect of resistance on
entomological indicators having an impact on disease transmission exist [60]. The number of
studies aimed at evaluating the operational significance of insecticide resistance on epidemio‐
logical outcomes of malaria remains nominal. This could be ascribed to multiple confounding
factors capable of complicating the interpretation of data. The most available evidence is
laboratory or experimental huts-based and harnessing entomological outcomes to assess the
impact resistance on mosquito biting rates, blood feeding rates, or insect mortality [153].
Conflicting findings on the impact of resistance on vectorial capacity has been reported with
some results indicating an increasing effect [156–160] while others present decreasing out‐
comes [159, 160].
Mostly, the impact of pyrethroid resistance is not clearly observable in entomological and
epidemiological terms. For instance, in areas with detected kdr resistance the distribution of
LLINs has been shown to successfully reduce malaria transmission [161]. Insecticide resistance
has only been directly implicated in operational control failure of pyrethroids in An. funestus
in South Africa [162]. In 1996, pyrethroid resistance compromised malaria control in KwaZulu
Natal following a switch of IRS insecticides from using DDT to deltamethrin [163]. The re-
introduction of IRS with DDT controlled the pyrethroid resistant An. funestus population and
malaria cases dropped by 91% [164]. In Bioko Island, IRS with pyrethroid had no impact on
kdr-mediated resistant An. gambiae population, but had significant impact on transmission
index and malaria cases [39, 42]. After switching to IRS with a carbamate, the mosquito
population declined [42]. In Burundi, programmatic IRS with pyrethroids and ITNs markedly
reduced Anopheles density by 82% and transmission intensity by 90% and occurrence of
clinical episodes by 43% in children despite high kdr frequencies in An. gambiae s.s. [40, 165].
In Côte d’Ivoire, ITN-randomised controlled trials demonstrated a significant reduction on the
entomological inoculation rate (55%) [166] and on malaria incidence in children <5 (56%) [167]
despite the presence of kdr-based pyrethroid resistance.
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The current information gathered across Africa indicates that there is rapid loss of efficacy of
most pyrethroids against malarial vectors [109, 168]. In Malawi, pyrethroid resistance did not
trigger an operationally significant epidemiological impact on malaria parasite prevalence in
children [114]. To compromise insecticide vector control, the level of resistance must be high
enough to adversely affect disease transmission [169]. Despite the observed decline of vector
abundance after the use of the pyrethroid derivatives [170, 171], the reported loss of efficacy
of these widely used insecticides should be taken as a major threat for potential resurgence of
malarial transmission in areas where gains have already been achieved against malaria vectors
[172]. In many cases, vector control may not be affected by the level of resistance but enhanced
surveillance and monitoring would be required [56]. This has refocused attention on the
production of chemicals that are efficient and cost-effective [161]. The impact of resistance on
the ability of the vector to transmit malaria is underexplored due to the scanty published
literature available. However, most studies use kdr alleles frequency as a proxy for resistance
due to the lack of molecular markers for alternative resistance mechanisms. This can be
misleading if metabolic or other resistance mechanisms are the predominant drivers of the
phenomenon. There is a need for additional attention to investigate on evolution and devel‐
opment of resistance to insecticides by disease vectors and consequently the epidemiological
impacts of malaria and other vector-borne diseases [153].
10. Resistance management strategies
The long-term control of vectors is threatened by insecticide resistance, which is occurring at
a faster pace than new insecticides are being developed. Pre-emptive action to mitigate the
development and spread of insecticide resistance is critical in preserving the limited arsenal
of insecticides available for public health [143]. With only four classes of insecticides currently
recommended for vector control, implementation of effective resistance management strat‐
egies remains inevitable [29]. Resistance management can be defined as “the containment of
the frequency of resistance genes below an acceptable threshold by means of strategic choices
of insecticide, dosage, mode of application, or frequency of use”[173]. The mutant alleles that
confer insecticide resistance are generated by random events. In the absence of insecticide
selection pressure, resistance management strategies take advantage of the adverse fitness
costs of resistance genes, to the insects carrying them. Though generally selected against in the
absence of selection pressure, alleles with strong pleiotropic effects increase in frequency when
insecticide selection pressure is applied. However, the outcome of resistance management
strategies can be affected by dominance status of the trait [29, 143].
Resistance management entails the development and implementation of control interventions
that minimise the likelihood that vectors will evolve strong resistance to important insecticides
[169]. The aim is to prevent or delay the onset of resistance in populations exposed to an
insecticide, or develop management programmes that cause existing resistance in populations
to decline, through rotating or alternating insecticides as a resistance management strategy
before resistance reaches measurable levels [174]. The use of combined classes of insecticides,
rotations of insecticides, or mosaic design has shown to overcome resistance problems
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effectively than using a single class of insecticide [175, 176]. Temporal rotation over time of
two, or preferably more, insecticide classes with different modes of action applied in an
alternating sequence is also based on the assumption that an individual mosquito does not
carry two resistant alleles [177]. Rotations are particularly effective if the resistance gene has
an associated fitness cost [87] and assumes that if resistance to each insecticide is rare, then
multiple resistances will be extremely rare [178]. The “mosaic” approach refers to applications
of different compounds against the same insect in spatially segregated locations [55] and aim
to preserve susceptibility by spatial restriction of insecticides [7]. Larger scale mosaics have
been shown to be effective for the management of pyrethroid resistance in An. albimanus in
Mexico [143, 179]. An alternative is simultaneous utilisation of a mixture of two or more
insecticides of unrelated mode of action, the aim being that resistance will evolve more slowly
to both insecticides than if either had been used on its own [180]. Unlike rotations, the
effectiveness of mixtures is not directly related to the degree of fitness cost. Mixtures of
insecticides require the expected frequency of resistant alleles at two different genetic loci to
be low and that individual mosquitoes carrying both alleles are rare [181]. The other approach
is through combinations of two vector control tools, such that a mosquito that survives contact
with one (e.g., LLIN) is exposed to the other one (e.g., IRS) [182]. The success of combinations
in effectively managing resistance depends on the ability to kill the vector despite the existence
of resistance by using another intervention or insecticide [183]. However, caution should be
exercised not to increase selection pressure by combining insecticides with same mode of
action (e.g., avoid pyrethroids for both IRS and LLINs) [86].
Ideally, insecticide resistance management should be undertaken using insecticide-based
approaches in conjunction with other non-insecticidal vector control methods, in the context
of IVM [3]. However, resistance surveillance is a fundamental step and insecticide suscepti‐
bility an indispensable resource of resistance management; it provides baseline data for
program planning and insecticide selection before the commencement of control operations,
facilitates detection of resistance at an early stage so that timely management can be imple‐
mented, and enables continuous monitoring of the effect of control strategies on resistance.
Establishing international, multi-disciplinary technical working groups with a clear reporting
system and defined responsibilities to facilitate data collation and rational policy transforma‐
tion is critical for optimal IRM strategies. This would require the presence of a multiplicity of
partners with vested interest in insecticide resistance, demand close collaboration and
sustained coordination of local and external technical experts, and require good stewardship
for them to succeed. Availability of entomological resources provides an ideal opportunity to
develop a rational IRM plan underpinned by entomological and epidemiological baseline data
to facilitate tracking of spatial and temporal resistance profiles of malaria vectors and evalu‐
ating its impact on the efficacy of control interventions. There remains a paucity of evidence
on the utility of conventional resistance management strategies (e.g., insecticide rotations,
mosaics, mixtures, and combinations) in restoring the susceptibility of malaria vectors. There
is also a need for well-designed assessments of the operational impact of combinations of
insecticidal and non-insecticidal interventions, including larval source management ap‐
proaches [87].
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11. Operational challenges of insecticide resistance management
The WHO has developed the GPIRM to help member states mitigate the development and
spread of resistance [7]. However, countries continue to experience substantial constraints for
effective deployment. First, there is limited country-level technical resource capacity to
support entomological intervention monitoring and evaluation, minimal essential physical
infrastructure and logistical resources to support implementation of the plan, including
insufficient qualified vector control workforce. Second, gaps in availability of reliable routine
monitoring data on vector bionomics, spatial distribution, insecticide resistance, underlying
resistance mechanisms, including operational cost of insecticide resistance from epidemiolog‐
ically representative sites, makes decision-making on resistance management difficult. Third,
deficiency in local financial support and sustainability that is threatened by donor dependency.
Fourth, timely scale up has been constrained by paucity in coordinating in-country entomo‐
logical resources, coupled with scepticism surrounding scientific findings by some key
national and international implementing and funding organisations. Fifth, skilled interna‐
tional technical assistance is a scarce resource that is overstretched. Sixth, there is limited data
on malaria transmission and its correlation to epidemiological indices to guide the targeting
of tools and monitoring of their impact. Seventh, poor data quality, management, and
willingness to share data by different partners is usually nominal and remain a challenge to
documenting insecticide resistance. Generally, there are limited resources and both human
and institutional capacity to fill these gaps. However, the potential of IVM provides a window
of opportunity that could be exploited for enhanced IRM activities.
Eight countries, Equatorial Guinea, Eritrea, Mozambique, Namibia, Rwanda, South Africa,
United Republic of Tanzania, and Zambia, currently have plans of implementing the GPIRM,
representing less than 10% of countries that need them. These plans are mainly reactive rather
than proactive. Two examples of countries with well-developed plans are Bioko, Equatorial
Guinea and Zambia [184]. Despite having good plans, the operational implementation of these
plans remains challenging. In Bioko, large-scale LLIN distribution and island-wide pyreth‐
roid-based IRS were conducted before a switch to bendiocarb IRS for eight years, after the
detection of kdr-based pyrethroid resistance. Despite kdr, there is evidence that pyrethroids
remain operationally effective. Therefore a bendiocarb-deltamethrin annual rotation has been
implemented. Pirimiphos-methyl remains a reserve option should this rotation fail, but was
considered too expensive to include initially despite the greater treatment longevity. In
Zambia, two major vectors (Anopheles funestus and An. gambiae sensus stricto) are resistant to
carbamates and pyrethroids and pyrethroids alone, respectively. A mosaic pattern of insecti‐
cide use, driven by the prevalence of the different vectors has therefore been implemented.
However, due to the increased cost, coverage has been reduced in a format that may adversely
impact disease transmission. Widespread pyrethroid resistance is now a major problem.
Getting new active ingredients to market quickly is imperative; large-scale randomised control
trials over many years to document efficacy may be unrealistic given the urgency [184].
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12. Policy implications of insecticide resistance
To maintain the effectiveness of vector control, countries are encouraged to deploy tools within
the context of IVM [3] and to pre-emptively implement suitable IRM strategies against malaria
vectors [7]. To help control programmes re-orient to IVM and IRM, strategic direction and
technical assistance have been provided for the two approaches. WHO guidance on IVM
includes: the Global Strategic Framework for IVM (2004) [3], the Report of the WHO Consul‐
tation on Development of a Global Action Plan for IVM [4], Guidance on Policy Making for
IVM [185], Core Structure for Training Curricula on IVM [186], Handbook for IVM [187], and
Monitoring and Evaluation Indicators for IVM [188]. Yet, only 62% of 113 endemic countries
globally and 53% of countries in Africa have national IVM policies and implemented the
strategy [184]. Moreover, resistance to at least one insecticide has been identified in 64 countries
with on-going malaria transmission [7]. The threat posed by insecticide resistance is high‐
lighted in the GPIRM consisting of five key pillars including: 1) planning and implementation
of IRM strategies in malaria-endemic countries; 2) ascertaining proper, timely entomological
and resistance monitoring coupled with effective data management; 3) the development of
new, innovative vector control tools; 4) filling of gaps in knowledge on mechanisms of
insecticide resistance and the impact of current IRM approaches; and 5) making available
enabling mechanisms such as advocacy and human and financial resources [7]. The current
monitoring of insecticide resistance is inadequate and inconsistent in most settings in which
vector control interventions are used. Often, monitoring is performed reactively or ad hoc,
depending on local research projects being conducted [7].
With the view to operationalise the GPIRM and optimise resistance monitoring and manage‐
ment, the WHO has developed a framework document for countries to use as a template for
their  insecticide resistance monitoring and management plans [189].  However,  very few
countries have established rational IRM strategies and incorporated them into operational
IVM-based vector control programmes. Notably, an emergency approach needs to be adopted
for  IRM with  continued  advocacy  for  the  GPIRM,  similar  to  that  given  to  Artemisinin
resistance  management  plans  is  essential.  Incorporating  other  vector-borne  disease  (i.e.,
dengue,  leishmaniasis,  etc.)  in  the  GPIRM  and  emphasising  biological  agents,  housing
improvement, and larviciding as IRM tools is crucial. For example, larviciding uses differ‐
ent classes of chemical insecticides and biological agents with different modes of action to
the four classes available for adult vector control and can reduce overall density [184]. The
current areas of focus within IVM include: redesigning programs in the context of insecti‐
cide resistance response and climate change; reorientation of programs with capacity building
and career pathways; encouraging intersectoral work; and IVM in emergency situations [184].
The WHO should address resistance and entomological capacity challenges via support to
countries for developing IRM plans, the inclusion of additional mechanism data in the global
database, bi-regional training, the development of a global insecticide resistance response
plan, and advocacy for action and resource mobilisation. In attempting to control and contain
the  spread  of  insecticide  resistance,  multi-country  cross-border  reporting  systems  and
proactive planning is also crucial to preserve new tools and should be considered to inform
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policy at this level, especially in light of the malaria elimination efforts that many countries
have embarked upon [168].
13. Using IVM for optimal IRM implementation
Given the backdrop of escalating resistance and limited vector control tools, as well as global
finances that continue to fall short of estimated requirements for malaria control and elimina‐
tion [2] and restricted entomological capacity [190], there has been some progress in the
implementation of the GPIRM [191]. A successful IVM programme includes actions along five
key strategic elements that can be harnessed for addressing the pillars of the GPIRM pertinent
to country-level strategic planning and implementation. First, Advocacy, social mobilisation,
and legislation: to strengthen national insecticide legislation and regulatory mechanisms for
their safe and judicious use; ensure insecticide resistance advocacy and communications to
effectively target policy makers, implementers, communities, and other stakeholders. Second,
Collaboration within the health sector and partners: to establish technical support linkages
with insecticide manufacturers and distributors for joint entomological monitoring, insecticide
selection, and resistance management; establish partnerships with the ministry of agriculture
and ministry of environment for supervision and pesticide management. Third, Capacity
building: to identify competencies and staffing levels essential for effective IRM; strengthen
human resource capacity through training for entomological resistance monitoring; establish
requisite infrastructure including insectaries, entomology labs; establish vector control data
management systems. Fourth, Evidence-based decision-making: clarify information needs and
data collection methods; establish entomological and epidemiological monitoring plans to help
target and evaluate interventions; select insecticides based on local data regarding vector
susceptibility and transmission ecology, ensure insecticide selection is based on an IRM plan
as outlined in the GPIRM; ensure vector control and vector data collection are completed in a
timely and rigorous manner; manage and utilise evidence for decisions and strategy refine‐
ment, including annual reassessment. Fifth, Integrated approach: ensure there is adequate,
evidence-based guidance on the impact of resistance on malaria vector control interventions;
evaluate whether agricultural use and other vector-borne diseases have an impact on resist‐
ance; explore additional non-insecticide complementary malaria vector control measures
where they may be appropriate [3, 4].
14. Conclusion and way forward
The development and implementation of national Insecticide Resistance Monitoring and
Management Plans for malaria control is crucial in operationalising the GPIRM. IVM can be
harnessed as a platform for strategic IRM planning. Thus, rational IRM strategies should be
an integral part of IVM-based malaria vector control programmes. However, significant
coordinated response among stakeholders and political commitment is needed for timely and
effective policy implementation within the context of a national health system.
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